RTW Biotech Opportunities (LON:RTW – Get Free Report) shares were up 1.2% during mid-day trading on Wednesday . The stock traded as high as GBX 1.26 ($0.02) and last traded at GBX 1.26 ($0.02). Approximately 495,137 shares were traded during mid-day trading, an increase of 129% from the average daily volume of 215,884 shares. The stock had previously closed at GBX 1.25 ($0.02).
RTW Biotech Opportunities Stock Performance
The business’s 50 day moving average is GBX 1.34 and its two-hundred day moving average is GBX 1.44. The firm has a market capitalization of £416.53 million, a PE ratio of 2.96 and a beta of 0.60.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW or RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
Recommended Stories
- Five stocks we like better than RTW Biotech Opportunities
- Business Services Stocks Investing
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
